In vitro growth kinetics of myeloid progenitor cells of myelodysplastic patients in response to granulocyte-macrophage colony-stimulating factor and interleukin-3.
Schipperus
M R
MR
Department of Haematology, University Hospital Dijkzig, The Netherlands.
Vink
N
N
Lindemans
J
J
Hagemeijer
A
A
Sonneveld
P
P
Abels
J
J
D002455:Cell Division / Q000187:drug effects; D002478:Cells, Cultured; D002869:Chromosome Aberrations; D003115:Colony-Stimulating Factors / Q000494:pharmacology*; D005870:Giant Cell Tumors / Q000378:metabolism; D016178:Granulocyte-Macrophage Colony-Stimulating Factor; D006133:Growth Substances / Q000494:pharmacology*; D006412:Hematopoietic Stem Cells / Q000187:drug effects*; D006801:Humans; D007377:Interleukin-3 / Q000494:pharmacology*; D007938:Leukemia / Q000209:etiology / Q000473:pathology; D009190:Myelodysplastic Syndromes / Q000150:complications / Q000235:genetics / Q000473:pathology*; D011994:Recombinant Proteins / Q000494:pharmacology; D012306:Risk
D003115:Colony-Stimulating Factors; D006133:Growth Substances; D007377:Interleukin-3; D011994:Recombinant Proteins; D016178:Granulocyte-Macrophage Colony-Stimulating Factor